Homozygous expression of the myofibrillar

myopathy-associated p.W2710X filamin C

variant reveals major pathomechanisms of

sarcomeric lesion formation by Schuld, Julia et al.
RESEARCH Open Access
Homozygous expression of the myofibrillar
myopathy-associated p.W2710X filamin C
variant reveals major pathomechanisms of
sarcomeric lesion formation
Julia Schuld1, Zacharias Orfanos1,2, Frédéric Chevessier3,4, Britta Eggers5, Lorena Heil1, Julian Uszkoreit5,
Andreas Unger6, Gregor Kirfel1, Peter F. M. van der Ven1 , Katrin Marcus5, Wolfgang A. Linke6,
Christoph S. Clemen3,7,8,9, Rolf Schröder3*† and Dieter O. Fürst1*†
Abstract
Filamin C (FLNc) is mainly expressed in striated muscle cells where it localizes to Z-discs, myotendinous junctions
and intercalated discs. Recent studies have revealed numerous mutations in the FLNC gene causing familial and
sporadic myopathies and cardiomyopathies with marked clinical variability. The most frequent myopathic mutation,
p.W2710X, which is associated with myofibrillar myopathy, deletes the carboxy-terminal 16 amino acids from FLNc
and abolishes the dimerization property of Ig-like domain 24. We previously characterized “knock-in” mice
heterozygous for this mutation (p.W2711X), and have now investigated homozygous mice using protein and mRNA
expression analyses, mass spectrometry, and extensive immunolocalization and ultrastructural studies. Although the
latter mice display a relatively mild myopathy under normal conditions, our analyses identified major mechanisms
causing the pathophysiology of this disease: in comparison to wildtype animals (i) the expression level of FLNc
protein is drastically reduced; (ii) mutant FLNc is relocalized from Z-discs to particularly mechanically strained parts
of muscle cells, i.e. myotendinous junctions and myofibrillar lesions; (iii) the number of lesions is greatly increased
and these lesions lack Bcl2-associated athanogene 3 (BAG3) protein; (iv) the expression of heat shock protein beta-7
(HSPB7) is almost completely abolished. These findings indicate grave disturbances of BAG3-dependent and
-independent autophagy pathways that are required for efficient lesion repair. In addition, our studies reveal
general mechanisms of lesion formation and demonstrate that defective FLNc dimerization via its carboxy-terminal
domain does not disturb assembly and basic function of myofibrils. An alternative, more amino-terminally located
dimerization site might compensate for that loss. Since filamins function as stress sensors, our data further
substantiate that FLNc is important for mechanosensing in the context of Z-disc stabilization and maintenance.
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Introduction
Heterozygous mutations in the human filamin C gene
(FLNC) located on chromosome 7q32 cause hereditary
and sporadic myopathies and cardiomyopathies with
marked phenotypic variability [18, 23, 32, 86]. The first
disease-causing FLNC mutations were described in the
context of skeletal myopathies displaying the classical fea-
tures of myofibrillar myopathies (MFMs; MIM# 609524),
which are morphologically characterized by sarcoplasmic
protein aggregates and degenerative changes of the myofi-
brillar apparatus [23, 67, 69, 86]. In addition, FLNC muta-
tions were subsequently demonstrated to cause distal
myopathies (MIM# 614065) without evidence for protein
aggregation [16, 26]. More recently, a growing number of
truncating and missense FLNC mutations have been iden-
tified in cardiac diseases comprising restrictive, hyper-
trophic, dilated and arrhythmogenic cardiomyopathies
(MIM# 617047) [4, 5, 9, 18, 25, 56, 78]. A very recent ex-
tensive review provides a complete overview of the cur-
rently known approximately 325 FLNC variants. A large
part of those are associated with skeletal myopathies and
cardiomyopathies [83].
Filamin C (FLNc) is a large, dimeric, actin-cross-
linking protein with a molecular mass of approximately
2 × 290 kDa. It is predominantly expressed in cross-
striated muscle cells, and localizes to myofibrillar Z-
discs, myotendinous junctions (MTJs), intercalated discs
and the sarcolemma [80]. Its modular molecular archi-
tecture, consisting of an actin-binding domain followed
by 24 immunoglobulin-like (Ig-like) domains, allows for
multiple simultaneous protein-protein interactions, mak-
ing FLNc a multi-adapter protein. Accordingly, more
than 90 proteins have been identified as FLNc ligands,
emphasizing its involvement in multiple scaffolding and
signaling functions in muscle cells [52, 79, 91]. The es-
sential role of FLNc for muscle development and main-
tenance is further highlighted by the effect of the
abolition of its expression in mice and zebrafish. Loss of
FLNc in mice causes a severe, perinatal lethal phenotype
including defects in embryonic myogenesis resulting in a
decreased number of primary fibers, excessive fiber size
variation, and disturbance of sarcomere architecture
[14]. In another mouse model, depletion of FLNc in the
embryonic heart resulted in fetal death, while loss of
FLNc in the hearts of adult mice caused severe dilated
cardiomyopathy in most mice, leading to early death
[92]. Corresponding studies in zebrafish demonstrated
myofibril failure and altered sarcomeric architecture, but
no effects on primary myogenesis [64].
In the present study, we explore the pathophysiology
of the human FLNC p.W2710X mutation [ClinVar:
NM_001458.4(FLNC):c.8130G > A (p.Trp2710Ter); Al-
lele ID: 33353], which in the heterozygous state is the
most frequently encountered human myopathy-causing
FLNC gene defect in various ethnic groups [37, 86]. It
must be noted that another mutation mainly appearing
in the population of Hong Kong [ClinVar: NM_
001458.4(FLNC):c.8129G > A (p.Trp2710Ter); Allele ID:
682327] leads to the expression of an identical protein
variant [44]. Both truncation mutations result in loss of
the 16 carboxy-terminal amino acids, thus impeding the
formation of dimers of Ig-like domain 24 of FLNc. As a
result, the mutant protein has a strong tendency to ag-
gregate and undergo proteolytic degradation [47, 86].
Our previously reported heterozygous p.W2711X knock-
in mice, harboring the murine orthologue of the human
FLNC p.W2710X mutation, represent the first patient-
mimicking genetic animal model for human filaminopa-
thies [11]. These mice primarily demonstrated that het-
erozygous expression of this pathogenic FLNc variant
results in myofibrillar instability with formation of
FLNc- and Xin-positive sarcomeric lesions [11]. To ex-
plore the pathomechanism of this mutation in skeletal
muscle more precisely, we now investigated mice homo-
zygous for the FLNC p.W2711X mutation (Hom mice).
These animals are viable and fertile, demonstrating that
the exclusive expression of at least this particular mutant
FLNc variant does not interfere with primary myogen-
esis. However, in comparison to wildtype (WT) and het-
erozygous animals [11], total FLNc levels were markedly
reduced and concomitantly the protein was strikingly
redistributed to areas of particular mechanic strain in
skeletal muscle fibers. Moreover, these mice showed in-
creased abundance of Z-disc streaming exemplified by
the presence of sarcomeric microlesions (spanning up to
five sarcomeres) and macrolesions (more than five sarco-
meres and across multiple myofibrils), thus highlighting
that FLNc might have a pivotal role for the structural
and functional integrity of the myofibrillar apparatus.
The dramatic decrease in the expression level of the
autophagy-related small heat-shock protein HSPB7 in
the muscle fibers of our Hom mice, and the absence of
BAG3 from myofibrillar lesions in these mice suggest a
cooperative role of these proteins in protection against,
and repair of sarcomeric damage.
Materials and methods
The Flnc p.W2711X knock-in mouse model
The Flnc c.8133G > A; p.W2711X knock-in mouse
model B6J.B6-Flnctm1.1Rsdf (http://www.informatics.jax.
org/allele/MGI:5907163) was generated as described be-
fore [11]. In brief, a point mutation in exon 48 of the
Flnc gene leading to the insertion of a stop codon in-
stead of a tryptophan residue was inserted by homolo-
gous recombination (GenOway, Lyon, France). The
mutation was extensively validated by different methods.
Genotyping was performed as described [11].
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Mice were housed in isolated ventilated cages (IVC)
equipped with spruce granulate embedding and a nest
under specific and opportunistic pathogen-free (SOPF)
conditions at 22 ± 2 °C, 50 to 70% air humidity, 70 air ex-
changes per h, and a light-dark-cycle of 12/12 h with free
access to water and food. Littermates were separated at
weaning by sex and housed at maximal five animals per
cage. Health monitoring was done as recommended by
the Federation of European Laboratory Animal Science
Associations (FELASA). Mice were handled in accordance
with the German Animal Welfare Act and the German
Regulation for the protection of animals used for experi-
mental purposes or other scientific purposes. All investi-
gations were approved by the governmental office for
animal care (reference number 84–02.05.40.14.057).
Histology, immunochemistry and light microscopy
Soleus muscles from WT and mutant mice (n = 3–4 per
genotype) were snap frozen in liquid nitrogen cooled iso-
pentane and stored at − 80 °C. To assess histology, 5 μm
thick transverse cryosections were stained with haematoxy-
lin and eosin (HE) and modified Gömöri trichrome, and for
cytochrome oxidase (COX) and succinate dehydrogenase
(SDH) activity according to standard procedures.
For immunostaining, 10 μm thick transverse or 6 μm
thick longitudinal cryosections were fixed with acetone
(− 20 °C) for 10 min or for 2 min with methanol (− 20 °C)
followed by 30 s acetone (− 20 °C), respectively. After fix-
ation, sections were rehydrated with phosphate-buffered
saline (PBS) and incubated with blocking medium (10%
normal goat serum in PBS) for 45 min at 37 °C. Sections
were incubated with primary antibodies diluted in 1%
bovine serum albumin (BSA) in PBS overnight at 4 °C.
After washing with PBS containing 0.05% Tween 20
(PBST), sections were incubated at 37 °C with the appro-
priate secondary antibodies diluted in 1% BSA in PBS
for at least 1 h. Slides were rinsed in PBS and dipped in
water before being mounted in Mowiol containing 0.25%
n-propyl gallate (Sigma P3130). Images were acquired
using an LSM710 confocal laser scanning or a Cell Ob-
server SD spinning disc microscope (Carl Zeiss GmbH,
Oberkochen, Germany).
Infrared western blot analysis and protein quantification
For comparative protein quantification, muscle samples
from 6 to 10-month-old WT and mutant mice were dis-
sected (n = 4 per genotype), weighed and snap frozen in
liquid nitrogen. Samples were mechanically disrupted
using a TissueLyser LT (Qiagen, Hilden, Germany) at
50 Hz and dissolved in 15 μl urea buffer [2M thiourea,
7M urea, 5 mM EDTA, 1 mM DTT and protease inhibi-
tors (Sigma, P8340) in 100mM Tris pH 8.6] per 1 mg of
muscle sample by homogenization for 3 min at 50 Hz.
Preheated SDS sample buffer was added to a final
concentration of 2-fold and samples were incubated for
5 min at 55 °C. After quantitative analysis of a
Coomassie-stained SDS-polyacrylamide gel, total protein
concentration of the lysates was adjusted. For compara-
tive quantitative blotting, identical total protein amounts
were separated by SDS-polyacrylamide gel electrophor-
esis (SDS-PAGE) as previously described [42] and trans-
ferred onto a polyvinylidenfluoride (PVDF) membrane
using a Transblot SD blot apparatus (BioRad, Munich,
Germany). Membranes were incubated with Odyssey
blocking buffer (LI-COR Biosciences, Bad Homburg,
Germany) for 30 min at room temperature and incu-
bated overnight at 4 °C with primary antibodies diluted
in Tris-buffered saline with 0.05% Tween 20 (TBST).
Subsequently, membranes were washed in TBST and in-
cubated with IRDye-680 or IRDye-800-conjugated sec-
ondary antibodies (LI-COR Biosciences, Bad Homburg,
Germany). Samples were analyzed using a LI-COR
Odyssey Infrared Imaging System (LI-COR Biosciences).
Integrated intensities of protein bands were quantified
using the Odyssey Infrared Imaging Software v. 3.0 (LI-
COR Biosciences) and normalized to α-tubulin or
glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Antibodies
The following antibodies were used in this study: anti-
FLNc RR90, recognizing FLNa and FLNc [80], the rabbit
sera FLNc d16–20 labelling Ig-like domains 16–20, and
FLNc WT recognizing the carboxy-terminal 16 amino
acids of Ig-like domain 24 of WT FLNc [11] were previ-
ously described. The mouse monoclonal antibodies
(mAbs) XR1, labelling the isoforms XinA and XinB [82],
T12 which recognizes a titin epitope close to the Z-disc
[22], BB78 against myomesin [84], the rat mAb YL1/2
against tyrosinated α-tubulin [88] and the rabbit serum
detecting sarcomeric α-actinin (RaA653) [80] have also
been described previously. Antibodies recognizing type I,
IIA IIX and IIB myosin heavy chain (MHC) isoforms
(BA-F8, SC71, 6H1, BF-F3, respectively) and anti-
dystrophin (MANDRA1) were obtained from Develop-
mental Studies Hybridoma Bank (DSHB, Iowa City,
USA). Anti-GAPDH (clone 5C6) was purchased from
Calbiochem/Merck Millipore (Darmstadt, Germany),
anti-vinculin (hVin-1, V9131) from Sigma Aldrich/
Merck, (Darmstadt, Germany), anti-slow MHC (NCL-
MHCs) from Novocastra/Leica Microsystems (Wetzlar,
Germany), and anti-BAG3 and anti-HSPB7 from
Proteintech, Manchester, UK. Secondary antibodies
conjugated to Texas Red, Alexa Fluor 488, 594, 647,
Cy2, Cy3 and Cy5 were from SouthernBiotech (Birming-
ham, AL, USA) or from Jackson ImmunoResearch (Ely,
UK). For more detailed information on antibodies see
Additional file 1: Table S1.
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RNA extraction and real-time quantitative PCR
To analyze Flna, Flnb and Flnc expression levels, RNA
was isolated from the soleus muscles of 8-month-old
WT and Hom animals using RNeasy Fibrous Tissue
Mini Kit (Qiagen, Hilden, Germany) in combination
with TissueLyser LT (Qiagen, Hilden, Germany). Gen-
omic DNA was eliminated by RNase-free DNase I treat-
ment. One microgram of total RNA was used for cDNA
synthesis by the Omniscript RT Kit (Qiagen, Hilden,
Germany) using random hexamer primers, according to
the recommendations of the manufacturer. Real-time
quantitative PCR reactions were performed using the
SsoFast EvaGreen Supermix (BioRad, Munich, Germany)
in a total reaction volume of 15 μl and the CFX96 real-
time PCR detection system (BioRad, Munich, Germany).
For quantification, all reactions were performed in tripli-
cates from 3 to 6 different cDNA samples prepared from
different mice. The expression levels obtained were nor-
malized to that of Gapdh and β2 microglobulin (B2m).
To determine the relative levels of mRNA expression be-
tween Hom and WT samples, ratios were calculated by
the ΔΔCT method [46] using the Biorad CFX manager
software version 3.1 and included a correction for ampli-
fication efficiency of the individual transcripts. Se-
quences of the applied oligonucleotides are provided in
Additional file 1: Table S2.
Electron microscopy
Soleus muscle samples from 8-month-old WT and mutant
mice (n= 2 per genotype) were immersed in Karnovsky fixa-
tive [33] containing 2.5% glutaraldehyde, 2% paraformalde-
hyde in 0.1M cacodylate buffer, pH 7.4 for 2 d at 4 °C. After
washing twice with 0.1M cacodylate buffer, samples were
trimmed to a smaller size and post-fixed in 1% OsO4 for 1 h
at room temperature. Samples were rinsed three times with
double distilled water and counterstained with 4% uranyl
acetate. Dehydration was carried out in a graded series of
ethanol (50, 70, 95% and twice in 100% ethanol) for 15min
each followed by 3 consecutive steps of propylene oxide
(Merck, Darmstadt, Germany). Samples were embedded in
Epon resin (Serva, Heidelberg, Germany) which was allowed
to polymerize for 48 h at 60 °C. To identify the specimens
containing micro- and/or macrolesions, 1μm thick semithin
sections were stained with toluidine blue and photographed
(Axio Imager M1, Carl Zeiss, Jena, Germany). From these
blocks 70 nm ultrathin sections were prepared (Ultracut S;
Leica, Germany) that were placed on 2 × 1mm copper slot
grids (Plano, Wetzlar, Germany) and examined with a Verios
460 L microscope (FEI - Thermo Fisher Scientific, Eindho-
ven, the Netherlands).
Protein interaction and crosslinking assays
A human FLNC cDNA fragment comprising Ig-like do-
mains 15–23 was amplified with a full-length FLNC
construct as template, and cloned into modified pAct2
and pLex vectors using standard protocols. Similarly,
truncated variants of this fragment were cloned into the
pLex vector. Transformation into L40 yeast cells, and
culturing and testing for β-galactosidase activity was per-
formed as described previously [81].
Protein cross-linking assays were performed essentially
as described [29]. In brief, His6-tagged recombinant pro-
teins were expressed in E.coli, purified using Ni-NTA
agarose, and dialyzed against cross-link buffer (CLB; 600
mM NaCl, 50 mM NaPi, pH 7.4, 1 mM MgCl2, and 1
mM DTT). Subsequently, 50 μl of a 10 μM protein solu-
tion in CLB was equilibrated at 37 °C for 10 min, and
0.5 μl of 65 mM ethylene glycol bis (succinimidyl succin-
ate) (EGS) in DMSO, or DMSO alone as a control, was
added. The mixture was incubated for a further 10 min
at 37 °C. After the reaction was stopped by addition of
SDS sample buffer and incubation for 10 min at 95 °C,
5 μl were analyzed by SDS-PAGE and western blotting
using an antibody against the immunotag of the recom-
binant proteins.
Glutathione S-transferase (GST) pulldown assays were
performed as described [51] using GST-tagged FLNc
d18–21, and His6- and T7-tagged FLNc d18–21 and
FLNc d15–17, respectively.
Laser microdissection, sample processing and mass
spectrometry
The identification of different fiber types before laser mi-
crodissection (LMD) was enabled by staining for anti-
slow MHC as described [89]. Non-fluorescent fibers
were classified as type II fibers. A total of 250,000 μm2 of
the sarcoplasmic area of fibers was excised, collected
and further treated for LMD as described [89], except
that samples were reduced in 6.7 mM dithiothreitol and
alkylated with 5 mM iodoacetamide. Approximately 200
ng peptides (16 μl) of each sample was used for label-
free quantitative mass spectrometric (MS) analyses, per-
formed on an UltiMate 3000 RSLC nano LC system
(Dionex, Idstein, Germany) as described [49]. After each
sample the column was equilibrated by a 1 h washing
step. The HPLC system was online-coupled to the nano
ESI source of a Q Exactive mass spectrometer (Thermo
Fisher Scientific, Germany). In the ESI-MS/MS analysis,
full MS spectra and MS/MS scans were performed as
described [10] with the exception that only ions with a
charge of + 2 and + 3 were selected for fragmentation.
Data analysis of mass spectrometry
Raw files were converted into mgf format using Prote-
ome Discoverer 1.4 (Thermo Fisher Scientific, Germany)
and then searched against a combined database contain-
ing the Swiss-Prot part of UniProt KB [76] for Mus mus-
culus (version 2018_06, 16,985 entries) and the common
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Repository of Adventitious Proteins as contaminant
database (version 2012.01.01, 115 entries). Shuffled
decoy entries were generated for each protein using
DecoyDatabaseBuilder [60]. For the identification of
spectra, a respective concatenated target-decoy-database
was used. Identifications were performed using Mascot
2.5 [Matrixscience Ltd., [59]], allowing 2 missed cleav-
ages, precursor tolerance of 5 ppm and fragment toler-
ance of 20 mmu. Carbamidomethylation (Cys) was set as
static and carbamidomethylation (Asn), deamidation
(Asn, Gln) and oxidation (Met) as variable modification.
A spectral counting workflow was created in KNIME
[version 3.5.3, [6]] to allow automated processing of
sample analysis. The mass spectrometry proteomics data
have been deposited to the ProteomeXchange Consor-
tium via the PRIDE [58] partner repository with the
dataset identifier PXD020097. Mascot dat files were used
as starting point. First, the samples were processed by
PIA [73, 77] to receive the peptide spectrum matches
(PSMs) needed for spectral counting. The false discovery
rate (FDR) was calculated for all files separately and an
FDR of 1% on PSM level was maintained. The resulting
PSMs were filtered for proteotypicity, i.e. only peptides,
which were assigned to exactly one protein in the given
database, were kept for further analyses. Here, the as-
signment to a contaminant was not considered to break
the proteotypicity. The number of PSMs for each protein
per run were normalized on all spectra per run, while
also the non-proteotypic identifications were counted.
These normalized counts are called spectral indices for
each protein.
In order to ensure comparability of the data with previ-
ous experiments on myofibrillar myopathy patients, statis-
tical analysis was performed as described [39, 48]. In brief:
to identify significantly differentially expressed proteins,
the ratio of the average spectral indices between pheno-
types were calculated and Student’s t-test was conducted
on the spectral indices for each protein. Proteins with a p-
value < 0.05 were considered as significantly differentially
expressed between the different phenotypes.
General data analysis and figure preparation
Data analysis and statistical evaluations were performed
using GraphPad Prism version 7 for Windows (Graph-
Pad Software, La Jolla, CA, USA) or Microsoft Excel
2016 in conjunction with the add-in “Real Statistics Re-
source Pack” version 5.5 by Charles Zaiontz, available at
http://www.real-statistics.com (version 3.2.3). Data are
given as median with IQR or as mean ± SEM. P-values
(Hom vs. WT) were calculated by Student’s t-test,
Kruskal-Wallis one-way analysis of variance and Mann–
Whitney U (Wilcoxon rank-sum) test and quoted * <
0.05, ** < 0.01, *** < 0.001 and **** < 0.0001 (precise
choice of test given in Figure legends). Final assembly of
the graphs and preparation of all figures was done using
Corel Draw Graphics Suite X7 (Corel, Austin, TX, USA).
Results
Filamin C is expressed at high levels in the soleus muscle
of mice
To determine which striated muscles express the highest
FLNc levels, protein extracts from different skeletal mus-
cles and the heart from WT mice were analyzed by
western blotting. Quantification using the LI-COR Odys-
sey Infrared Imaging System demonstrated that the ex-
pression level of FLNc in the soleus muscle is
significantly higher than in all other skeletal muscles, the
diaphragm or the heart (Fig. 1a). For this reason, we de-
cided to analyze the effects of the expression of only mu-
tant FLNc in soleus muscle.
Comparison of the expression levels of filamin C mRNA
and protein in WT and Hom mice
Reverse transcription quantitative polymerase chain re-
action (RT-qPCR) to analyze Flnc mRNA expression re-
vealed no significant differences between total Flnc
mRNA levels in the soleus muscles of WT and Hom ani-
mals (Fig. 1b). Similarly, expression levels of Flna and
Flnb mRNA were analyzed. Their expression levels were
not significantly increased in soleus muscles of Hom
mice (Fig. 1c).
We then analyzed the FLNc protein levels in our mice
by western blotting, using two different antisera: one, di-
rected against Ig-like d16–20, recognizes all FLNc,
whereas the second one is directed against the 16
carboxy-terminal amino acids absent in the mutant and
only reacts with the WT protein. This revealed that the
total FLNc level in Hom mice was reduced to approxi-
mately 40% of that in WT mice (Fig. 1d, e). Staining with
the second antiserum gave no signal in the Hom mice,
confirming the complete absence of WT FLNc and the
exclusive expression of mutant FLNc in those animals
(Fig. 1d, e). We further confirmed this by proteomic ana-
lysis of the FLNc expression level in different fiber types
of the soleus muscle of Hom and WT animals. In ac-
cordance with the data obtained by western blotting, in
type I and type II fibers FLNc levels were reduced to
46.1 and 40.3% of the corresponding levels in WT
muscle fibers, respectively (Fig. 2c).
Comparison of expression levels of proteins represent-
ing different sarcomeric sub-assemblies by quantitative
western blotting did not reveal any significant differ-
ences in M-band, Z-disc, intermediate filament and A-
band proteins or the muscle damage marker Xin (Fig.
2a, b) between WT and Hom mice. These data were
grossly confirmed by proteomic analysis (Fig. 2c). By
contrast, expression levels of the small heat shock pro-
tein HSPB7 (cvHsp, Hsp25–2) were hardly detectable in
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the muscle fibers of our Hom animals. Again, our western
blot data were confirmed by proteomic analysis (Fig. 2a-
c). Notably, the latter method, based on MS analysis did
not detect a single HSPB7 peptide in 90% of the samples
acquired from type I or type II fibers derived from Hom
mice. In addition, proteomic analysis indicated that FLNa
and FLNb are neither expressed in the sarcoplasm of type
I, nor of type II fibers (Fig. 2c). Protein levels of the
chaperone-assisted selective autophagy (CASA)-related
SYNPO2 (synaptopodin-2) protein were significantly in-
creased in type II fibers of Hom mice, whereas type I fi-
bers also showed a slight, but non-significant increase.
Several other autophagy-related proteins were also in-
creased in especially type II fibers (Fig. 2c).
Homozygosity for the Flnc p.W2711X mutation causes a
myopathic phenotype
In transverse cryosections from soleus muscles of adult
(8–10months) and aged (20months) WT and Hom mice
(4 mice per genotype) stained with haematoxylin and
eosin (HE; Fig. 3a), we investigated the number of fibers
with centrally located nuclei. Numbers were statistically
evaluated using a chi-squared test and demonstrated an
increase in the number of centrally located nuclei in adult
Hom animals (Hom: 4.40 ± 0.52 vs WT: 1.28 ± 0.44, n = 3,
p = 0.0033) and even more in aged Hom animals (Hom:
9.13 ± 1.16, n = 4 vs WT: 1.1 ± 0.40, n = 3, p < 0.0001, Fig.
3b; Kruskal-Wallis test, Chi-square). Soleus muscles of
Hom animals showed a slight increase of endomysial con-
nective tissue, a rounding of muscle fibers and multiple
atrophic muscle fibers. In addition, Hom soleus muscles
contained degenerating fibers, which were never observed
in WT muscles (Fig. 3a). Moreover, in nearly all soleus
muscle samples the conspicuous presence of areas with
increased fibrosis sometimes resembling myotendinous
junctions was noted (Fig. 3a, asterisk). Staining with modi-
fied Gömöri trichrome, SDH and COX showed no evi-
dence of mitochondrial abnormalities in Hom animals
(Additional file 1: Figure S1).
To investigate the effect of mutant FLNc expression on
fiber type and fiber size distribution in Hom animals,
cryosections of soleus muscles were analyzed for expres-
sion of fiber type specific MHC, followed by statistical
evaluation (Supp. Figure S2A-C). This revealed that fiber
type composition is not significantly different in the soleus
muscles of Hom mice compared to WT mice (Additional
file 1: Figure S2B,C). Moreover, fiber number and fiber
size (minimal diameter) were analyzed in cryosections
stained for dystrophin. Adult and aged Hom soleus mus-
cles contained significantly fewer fibers (Mann-Whitney
Fig. 1 FLNc expression in different mouse muscles, and soleus muscle of wildtype and Hom mice. a Protein quantification in different wildtype
mouse muscles demonstrated highest FLNc expression levels in soleus muscle. Anti-GAPDH was used as loading and normalization control. n = 5.
EDL: Musculus (M.) extensor digitorum longus; Gast: M. gastrocnemius; Quad: M. quadriceps; TA: M. tibialis anterior; Sol: M. soleus; Dia: diaphragm.
b Quantitative real time PCR showed virtually identical total Flnc mRNA levels in adult WT and Hom animals (n = 4–6). c Comparison of Flna and
Flnb mRNA expressions using the Biorad CFX manager software version 3.1 and Student’s t-test revealed no significant differences in Hom
animals (n = 4–6). d, e Western blotting of total soleus muscle extracts from adult mice using an antibody recognizing both, WT and mutant FLNc
(FLNc total) in conjunction with protein quantification using a LI-COR Odyssey Infrared Imaging System. Statistical analysis using Mann-Whitney
U-testing indicated a significant reduction to approximately 40% of total FLNc expression in Hom animals. Results are shown as mean +/− IQR
(n = 4; p = 0.0286). Staining with an antiserum recognizing the carboxy-terminal 16 amino acids of FLNc (and thus only WT FLNc) confirmed its
complete absence in Hom animals (n = 3)
Schuld et al. Acta Neuropathologica Communications           (2020) 8:154 Page 6 of 19
U-test, 6 mice per genotype; adult: WT: median 795 fibers,
IQR 266 vs Hom: 614 fibers, IQR 245, p = 0.0152; aged:
WT: median 858 fibers, IQR 75 vs Hom: 596 fibers, IQR
155, p = 0.0043) (Fig. 3c), although soleus muscle weight
compared to body weight was not decreased. This lack of
fibers was compensated by a significantly increased fiber
size for MHC I-positive fibers in adult Hom mice (Krus-
kal-Wallis with post-hoc analysis using the Mann-
Whitney U-test) 3 mice per genotype; WT: 31.3 μm; 275
fibers, IQR 7.4 vs Hom: 34.8 μm; 216 fibers, IQR 9.2, p <
0.0001) as well as MHC IIA-positive fibers in both, adult
and aged Hom mice (3 mice per genotype; adult: WT:
28.3 μm; 623 fibers, IQR 5.0 vs Hom: 31.4 μm; 422 fibers,
IQR 6.0; 3 mice per genotype, p < 0.0001; aged: WT:
34.7 μm; 560 fibers IQR 5.0 vs Hom: 35.6 μm; 326 fibers,
IQR 7.6;, p = 0.0061) (Fig. 3d-g). By contrast, the size of
MHC I-positive fibers in aged mice (3 mice per genotype),
was significantly reduced in Hom mice: WT: 36.5 μm; 407
fibers, IQR 5.5 vs Hom: 34.1 μm; 452 fibers, IQR 8.4; p <
0.0001. (Fig. 3d-g).
Reduced expression and altered distribution of mutant
filamin C in Hom mice
Cross sections of soleus muscles were analyzed for
localization of FLNc and the muscle damage marker Xin.
Whereas in the muscle fibers of WT animals FLNc was
homogeneously expressed in all muscle fibers, soleus mus-
cles from Hom animals only showed minimal staining
(Fig. 4a). Instead, brightly stained foci were observed that
also contained Xin, indicating that these structures repre-
sented muscle damage areas. Analysis of the Xin-positive
area compared to the complete area of muscle fibers indi-
cated that Hom fibers displayed significantly more muscle
damage (median of lesion area in % of WT: 0.48 vs Hom:
1.97; p = 0.0022; 6 mice per genotype; Mann-Whitney U-
test Fig. 4b). Staining of longitudinal sections unequivocally
Fig. 2 Expression of sarcomeric and autophagy-related proteins in wildtype and Hom soleus muscle. a Western blotting revealed no differences
in expression of the M-band component myomesin, the Z-disc component α-actinin2, intermediate filaments (desmin), the thick filament
component MHC IIa, the muscle damage marker Xin and the molecular chaperone regulator BAG3, whereas the small heat-shock protein HSPB7
showed a striking reduction in Hom mice. GAPDH was used as loading control. b Quantification of the results shown in panel A revealed no
significant differences in the expression levels of all analyzed proteins, except for the almost complete absence of HSPB7 in Hom mice (n = 4; p =
0.0286; Mann-Whitney U-test). c Proteomic analysis of laser dissected sarcoplasma of soleus muscle fibers from Hom and WT mice confirmed that
the proportion of FLNc in Hom mice was reduced to 46 and 40% in type I and type II fibers, respectively, whereas FLNa and FLNb were not
detectable. Investigation of other proteins tested by western blotting, revealed a slight underrepresentation of α-actinin2, whereas myomesin,
desmin and Xin levels were not changed. Note that MHC IIa is not yet represented in the UniProt KB database [76], and could therefore not be
detected in the mass spectrometric analyses. The autophagy related protein HSPB7 was hardly detectable in both fiber types of Hom mice,
whereas other small heat shock proteins such as HSPB1 and HSPB5 are significantly upregulated in type II fibers. Notably, other autophagy-related
proteins, such as synaptopodin-2, VPS11, STK11 and RAB-33B also show a significantly increased expression in type II fibers of our Hom mice
(Student’s t-test)
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identified these intensely stained structures as sarcomeric
micro- and macrolesions, rather than amorphous aggre-
gates (Fig. 4c). Whereas in WT soleus muscles large quan-
tities of FLNc were localized to Z-discs, in Hom muscle
fibers staining of Z-discs was far less intense. Instead, FLNc
was detected mainly in lesions and MTJs (arrowheads in
Fig. 4c; Additional file 1: Figure S3). The signal intensity of
FLNc localized to these structures was compared to that of
titin using the Zen software line profile tool of the confocal
microscope (Fig. 4d) and by comparison of the mean FLNc
grey value normalized to the titin grey value in individual
Z-discs (Fig. 4e). Statistical analysis using Kruskal-Wallis-
and subsequent Mann-Whitney U-test revealed a highly
significant reduction of signal intensities of FLNc in the Z-
discs of Hom soleus muscle fibers (Fig. 4e).
Distribution of titin and filamin C in macrolesions
Previously, we identified FLNc and Xin as major com-
ponents of micro- and macrolesions, that are supposed
to protect myofibrils against further damage [43, 55].
Analysis of our adult Hom animals revealed high levels
of FLNc in these lesions (Fig. 4a, b, Fig. 5a) that showed
non-homogeneous FLNc signal intensities (Fig. 5b, c).
Co-staining for a Z-disc epitope of titin (Figure 5B,C)
combined with a line profile showed that areas with re-
duced FLNc signals precisely overlap with Z-discs. The
distance between Z-disc titin signals within the lesions
was approximately 7.2 μm, while in normal appearing
sarcomeres the spacing was 2–2.5 μm.
The increased staining for FLNc in MTJs of Hom ani-
mals (Fig. 4c), prompted us to directly compare signal
intensities of FLNc in these structures. Double staining
with an antibody against vinculin to identify MTJs,
showed a more intense staining in Hom mice, indicating
strong accumulation of mutant FLNc in the MTJs of
these mice (Additional file 1: Figure S3).
Sarcomeric pathology at the ultrastructural level
Light microscopy of toluidine blue stained semi thin sec-
tions from Epon embedded soleus muscle of adult Hom
Fig. 3 Histological staining and analysis of fiber size, fiber number and fiber type in M. soleus. a Hematoxylin and eosin-stained transverse
cryosections of WT and Hom mice. The sections of the Hom mice show increased fibrosis (asterisk), several fibers with central nuclei (black
arrowheads), and very small fibers (arrows) and degenerating fibers in the aged Hom mice (white arrowheads), indicating an increased myopathic
phenotype in these animals. b Statistical evaluation of respective percentages of fibers with centrally located nuclei using Kruskal-Wallis test and
chi-squared independence tests. The number of muscle fibers with centrally located nuclei is significantly increased in adult and aged Hom
animals (adult: n = 6; p = 0.0033; aged: n = 6, p < 0.0001). c The total number of fibers is significantly lower in the soleus muscle of Hom animals
(adult: n = 6; p = 0.0152; aged: n = 6, p = 0.0317). d-e When compared to WT mice, the mean minimal diameter of type I fibers is significantly
larger in adult Hom animals (****p < 0.0001), whereas they are smaller in aged mice (****p < 0.0001), indicating that in Hom mice type I fibers
don’t increase their size as much as in WT animals during aging. f-g When compared to WT mice, the mean minimal diameter of type II fibers is
significantly larger in adult and aged Hom animals (****p < 0.0001, **p = 0.0061)
Schuld et al. Acta Neuropathologica Communications           (2020) 8:154 Page 8 of 19
mice revealed extended dark appearing regions lacking
the typical cross striated pattern of the surrounding
myofibrils (Fig. 6a). Ultrathin sections of specimens con-
taining such regions with a perfect longitudinal
orientation were analyzed by transmission electron mi-
croscopy. This confirmed the presence of sarcomeric
macrolesions, and showed that they always start at one
Z-disc and end at another Z-disc (Fig. 6b). Within
Fig. 4 Muscle damage and FLNc content in soleus muscles of adult WT and Hom mice. a Immunostaining of soleus muscle cross sections for
muscle damage marker Xin reveals increased muscle damage in Hom animals. FLNc colocalizes with Xin in damage areas. Note that identical
scan settings were applied. b Statistical analysis of the area of muscle damage using the Mann-Whitney U-test reveals significantly increased
damage in Hom mice: median of lesion area in % of total muscle area, 0.48 in WT versus 1.97 (n = 6 in each group; p = 0.0022). c-e Comparison
of FLNc and titin expression levels in soleus muscle of wildtype and Hom mice. c Double staining of longitudinal sections of soleus muscle for
FLNc and an epitope of titin close to the Z-disc shows significantly reduced levels of FLNc in Z-discs of Hom mice. Note that identical scan
settings were used. Instead, FLNc was found highly concentrated in lesions (asterisks) and MTJs (arrows). d Illustration of Zen software line profiles
of the mean immunofluorescent intensities of FLNc and titin in Z-discs of WT and Hom mice using the line profile option of the microscope and
Zen 2 software Version 2.0.0.0. Note comparable intensities of FLNc and titin signals in Z-discs of wildtype mice but reduced FLNc intensity in
Hom mice. e Quantification of FLNc Z-disc signal corrected against the background and normalized against titin confirms a highly significant
reduction of FLNc levels in Z-discs in Hom mice. Statistical analysis was performed for sections from 3 mice of each genotype and in each 10 Z-
discs were included in the calculations. Kruskal-Wallis test one-way analysis of variance; post-hoc analyses by performing Mann-Whitney U-tests of
both groups (median of WT: 1.16, median of Hom: 0.22; p < 0.0001). For all experiments the RR90 antibody was used to detect FLNc. Bars: 200 μm
(a), 10 μm (c), 5 μm (d)
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Fig. 5 (See legend on next page.)
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(See figure on previous page.)
Fig. 5 Distribution of FLNc and titin in myofibrillar lesions. a Longitudinal cryosections of soleus muscle from an adult Hom mouse stained for
FLNc and titin. The upper panel shows an image with increased gain settings necessary to reveal localization of mutant FLNc in Z-discs. Macro-
and microlesions are strongly stained. The middle panel shows the identical part of the section with a gain setting enabling localization of FLNc
within lesions. The lower panel shows a second fiber with a macrolesion. Boxed areas are shown enlarged in panels b and c. Note the highly
extended distance between Z-discs within lesions, and the localization of FLNc between Z-discs. b Line profile of the boxed area in a (middle
panel) confirms increased signal intensity of FLNc in filamentous appearing structures between Z-discs, while FLNc signals are decreased exactly
at the position of the Z-discs. The distance between individual Z-discs increased from 2 to 2.5 μm in normal myofibrils to approximately 7.2 μm
(mean distance: 7.21 ± 0.73 μm) in lesions. c Line profile of the boxed area in a (lower panel). Note a single normal appearing sarcomere within
the macrolesion (asterisk) and the absence of FLNc in this area, whereas the space between the titin signals within the lesion is completely filled
with FLNc (arrows). RR90 antibody was used to detect FLNc in a (lower panel), b and c. Polyclonal rabbit antiserum against FLNc d16–20 was
used in a (upper panels). Bars: 10 μm (a), 10 μm (b), 5 μm (c)
Fig. 6 Soleus muscle of Hom mice at the ultrastructural level. a Longitudinal semithin section of Epon embedded soleus muscle of an adult Hom
mouse stained with toluidine blue. Shown is a section with two neighboring darkly stained macrolesions (arrows). Note numerous elongated and
swollen mitochondria (arrowheads). b Transmission electron microscopy of an ultrathin section similar to the section shown in A. Depicted are
two macrolesions (arrows) surrounded by normally appearing myofibrils. Also, here many elongated and swollen mitochondria are observed
(arrowheads). c A section containing three microlesions (arrows). The boxed microlesions are shown enlarged in panels di-diii. Bars: 5 μm (a, c),
10 μm (b), 2.5 μm (di-diii)
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macrolesions the normal sarcomere layout of I-bands,
A-bands, Z-discs and M-bands was abolished and the
space between flanking Z-discs was filled with partially
filamentous electron dense material. Notably, these areas
were also devoid of mitochondria (Fig. 6b). In addition
to macrolesions, many microlesions were observed (Fig.
6c-d), resembling the lesion pathology observed in MFM
patient samples. Most microlesions typically extended
over a single sarcomere that seemed to gradually lose the
normal organization of thin and thick filaments (Fig. 6di),
and displayed increasingly disorganized filamentous mater-
ial. Simultaneously, the distance between the flanking
Z-discs increased (Fig. 6dii-diii). Furthermore, we fre-
quently observed rows of elongated and swollen intermyo-
fibrillar mitochondria (Fig. 6a-c) as well as subsarcolemmal
autophagic vacuoles (not shown) as previously described
for heterozygous p.W2711X animals [11].
Analysis of BAG3 and HSPB7 localization in muscle fibers
from WT and Hom mice
Pathways involved in elimination of misfolded or dam-
aged proteins by autophagy involve BAG3 and HSPB1,
HSPB5 and HSPB8, whereas HSPB7 functions independ-
ently from BAG3. We analyzed which of these proteins
are associated with myofibrillar lesions in WT and Hom
muscle fibers. Antibodies against BAG3 as well as
HSPB7, brightly stained lesions and Z-discs in muscle fi-
bers from WT mice (Fig. 7a, b, upper panels). By con-
trast, in the muscle fibers from Hom animals, BAG3
only localized to Z-discs and was not detected in lesions
(Fig. 7a, lower panel). The small amounts of HSPB7 that
were still expressed in Hom muscle fibers mainly local-
ized to lesions (Fig. 7b, center panel).
Identification of a putative alternative dimerization site in
filamin C
Our previous work demonstrated that the FLNC
p.W2710X mutation abolishes the dimerization property
of its Ig-like domain 24 [47, 86]. Indications for the pres-
ence of an alternative dimerization site within the rod 2
domain of FLNb [70] prompted us to investigate whether
also FLNc might have a second dimerization site. We
therefore tested the interaction of a construct encompass-
ing FLNc Ig-like domains 15–23 with several other frag-
ments in the yeast-two-hybrid system. Indeed, several
fragments interacted (d15–23, d18–21, d19–21), whereas
several others (d15–17, d16–19, d21–23) did not. This
identified Ig-like domains 19–21 as the smallest interact-
ing fragment. Notably, deletion of the FLNc-specific inser-
tion in Ig-like domain 20 abolished this interaction
(Fig. 8a). To confirm this interaction biochemically, we
performed cross-linking assays with FLNc Ig-like domains
18–21, similar to those used to show dimerization of Ig-
like domain 24 [29, 47]. This resulted in higher molecular
mass complexes compatible with oligomerization of this
FLNc fragment. As noticed in yeast-two-hybrid assays, de-
letion of the insertion in Ig-like d20 prohibited the inter-
action. By contrast, a comparable construct comprising
FLNa d18–21 did not seem to interact with itself in this
assay (Fig. 8b). To confirm this interaction, we also per-
formed pull-down assays in which a GST-FLNc d18–21
fusion protein bound to GSH-beads interacted with FLNc
d18–21, but not with FLNc d15–17 (Fig. 8c). This indi-
cates that FLNc lacking Ig-like domain 24, and probably
also the p.W2710X mutant variant, might still be able to
dimerize or oligomerize.
Discussion
Until now more than 200 dominant human mutations in
the FLNC gene have been identified to be associated with
a great variety of myopathies and cardiomyopathies [83].
In addition, very recently a first case of a homozygous, re-
cessive FLNC mutation (NM_001458.4:c.1325C >G;
p.P442R) was reported to cause a severe congenital myop-
athy associated with degenerated myofibrils, advanced sar-
comeric lesions and protein aggregates containing FLNc,
Xin and XIRP2 in patient muscle fibers [40]. In extension
to our previous work on human p.W2710X filaminopa-
thies and patient-mimicking heterozygous Flnc p.W2711X
knock-in mice [11, 36–38, 47, 86], we therefore character-
ized mice homozygous for this mutation. Our hypothesis
was that the sole expression of mutant FLNc, containing a
truncated, dimerization-incompetent Ig-like domain 24,
would enhance pathological processes, thus allowing more
precise analysis of the underlying pathomechanisms. One
key finding is that, although general striated muscle devel-
opment and sarcomere formation are not interfered in
these mice, even sedentary animals develop a myopathic
phenotype in conjunction with a fulminant sarcomeric le-
sion pathology. By contrast, mice in which the Flnc exons
encoding Ig-like domains 21–24 were deleted (Flnctm1Lmk,
http://www.informatics.jax.org/allele/key/35197) display
neonatal lethality caused by defects in primary myogenesis
[14], while inducible cardiac-specific ablation of Flnc ex-
pression resulted in embryonic death, or death associated
with dilated cardiomyopathy in adult mice, respectively
[92]. One mechanistic difference explaining the different
phenotypes is the fact that the mutations in the latter two
mouse models result in highly reduced Flnc mRNA ex-
pression, most likely caused by nonsense mediated decay
(NMD), and consequently hardly or no detectable levels
of mutant FLNc protein [14, 92]. Therefore, their lethal
phenotype has to be attributed to a complete loss of FLNc
function. By contrast, the p.W2711X mutation, residing in
the last exon, bypasses NMD, resulting in expression of
Flnc mRNA at normal levels. This, in turn, implies that
the reduced level of mutant protein in our Hom mice is
most likely the result of increased FLNc protein
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degradation. Notably, FLNC is a dosage-sensitive gene and
reduced expression of FLNc causes myopathies [26], indi-
cating that the highly reduced FLNc protein level of our
Hom mice is a major mechanism contributing to their
phenotype. In this respect it is interesting to note that
mass spectrometry analysis of skeletal muscle fibers of het-
erozygous p.W2711X mice indicated that FLNc levels are
reduced to 85.0% (p = 0.035) and 70.1% (p = 0.0054) in type
I and type II fibers, respectively (ProteomeXchange submis-
sion PXD020097). These differences were previously not
detected by non-quantitative western blotting [11].
It is difficult to separate the effect of the reduction of
FLNc from that of the expression of mutant FLNc in our
mice. Surprisingly few data are available on FLNc expres-
sion levels in myopathy patients with an FLNc mutation.
In a family with a nonsense mutation (p.F1720LfsX63)
that leads to NMD of the mutant mRNA and reduced ex-
pression of only wildtype FLNc, the phenotype is compat-
ible with distal myopathy without the typical signs of
MFM such as protein aggregation [26]. Patients with an in
frame deletion mutation in Ig-like domain 7 (p.V930_
T933del) express normal or even increased levels of FLNc
[69], and expression of this unstable and misfolded protein
[38] is associated with the formation of aggregates and le-
sions [11, 38, 69]. A patient with a homozygous p.P442R
mutation in Ig-like domain 2 expressed a normal level of
unstable FLNc protein and his muscle fibers contained
Xin- and FLNc-positive aggregates [40]. This indicates
that low FLNc expression levels cause a myopathic pheno-
type without or with limited aggregates or lesions, whereas
the expression of toxic FLNc protein results in lesion and/
or aggregate formation.
Fig. 7 Immunolocalization of BAG3 and HSPB7 in muscle fibers of adult wildtype and Hom animals. a In WT fibers BAG3 colocalizes together
with FLNc in myofibrillar lesions and Z-discs identified with an antibody against an epitope of titin close to the Z-disc. In Hom muscle fibers,
BAG3 localizes to Z-discs, but not to lesions. b In WT fibers also HSPB7 colocalizes with FLNc in myofibrillar lesions and Z-discs. In Hom muscle
fibers, the small amount of HSPB7 that is expressed mainly localizes to lesions. Note that in all cases, identical scan settings were applied. For all
experiments the RR90 antibody was used to detect FLNc. Bars: 5 μm
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FLNc is degraded by multiple pathways, including
CASA [1, 74], proteasomal degradation [2], and cleavage
mediated by calpain 3 [27] or KY protein [3]. Particularly
important components for the detection and elimination
of damaged FLNc are small heat-shock proteins (sHSPs).
The increased expression level of HSPB1, HSPB5 and
HSPB8 (and other autophagy-related proteins) especially
in type II fibers of our Hom mice (Fig. 2c) points at en-
hanced autophagic activity. In accordance, in the muscle
fibers of MFM-filaminopathy patients, HSPB1 and HSPB5
are strongly upregulated, translocated away from Z-discs
[75] and highly concentrated in pathologic aggregates
[39]. Notably, these sHSPs interact and cooperate with the
co-chaperone and key CASA component BAG3. A major
difference between WT, heterozygous p.W2711X and
Hom mice is that only in Hom mice BAG3 is not a com-
ponent of myofibrillar lesions. This implies that an im-
portant mechanism contributing to the pathophysiology
of the p.W2711X mutation is a lack of full CASA func-
tionality that would be necessary for sufficient repair of
the enhanced lesion formation in our Hom mice.
By contrast, the expression level of HSPB7 is highly re-
duced in the muscle fibers of Hom mice. HSPB7 interacts
with the dimerizing domain 24 of FLNc, but not with the
p.W2710X variant [31]. HSPB7 was proposed to facilitate
early post-damage processing of FLNc and titin [50] and it
functions independently from BAG3 [87]. In mice, the
complete lack of HSPB7 leads to a progressive myopathy
associated with disarray of myofibrils [31]. Cardiac-
specific HSPB7 ablation even results in embryonic lethal-
ity, concomitant with abnormal actin filament bundles
(AABs) within sarcomeres, ultimately resulting in myofib-
ril disorganization [90]. AABs resemble the microlesions
we observed in mouse hearts after aortic constriction and
in the skeletal muscle fibers of our p.W2711X mice and
MFM patients [11, 34]. These AABs lack tropomyosin,
troponin, MyHC and myomesin and are non-contractile
[90]. We propose that only in the absence of these pro-
teins, actin cross-linking proteins like FLNc and Xin [57]
can bind and stabilize these actin filament bundles. The
extremely low expression level of HSPB7 in Hom mice
and its inability to interact with mutant FLNc is therefore
implied as a major disease mechanism aggravating myofi-
brillar instability and resulting in increased abundance of
micro- and macrolesions. Accordingly, interference with
HSPB7 expression in zebrafish and human cardiomyo-
cytes also results in increased load by damaged proteins
and stimulation of autophagic pathways [50]. Further
studies are necessary to resolve the cause for its strongly
reduced expression in our Hom mice, and to elucidate its
precise role, both in actin-based assembly and regulation
of autophagic pathways [13].
In p.W2711X FLNc only Ig-like domain 24 is mis-
folded, whereas the other 23 domains remain intact and
functional. It is therefore reasonable to assume that most
of the functionality of the WT protein is retained, which
Fig. 8 Analysis of a putative second dimerization region in FLNc. a Yeast-two-hybrid experiments investigating interaction of FLNc Ig-like
domains 15–23 (prey) with different fragments of FLNc as baits. Interaction was found with d15–23, d18–21 and d19–21 of FLNc. Note that
deletion of the FLNc specific insertion in Ig-like domain 20 (d19–21Δ) abolished the interaction. +: interaction; −: no interaction. b FLNc d18–21
with and without (Δ) insertion in d20, and FLNa d18–21 were incubated in the presence of the cross linker EGS. Separation by PAGE and western
blotting with an antibody against the immunotag of the recombinant fragments indicated oligomerization of FLNc d18–21 (arrow) but not of the
other constructs. c GST pull down assay indicating that GST-FLNc d19–21 (GST + FLNc) binds T7-tagged FLNc d19–21, but not T7-tagged FLNc
d15–17. GST alone does not bind any of the FLNc fragments. lc: loading control showing the correct size of the FLNc fragments
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might explain the still relatively subtle phenotype. Het-
erozygous p.W2711X knock-in mice, which express a
mixture of WT and mutant FLNc, revealed an even
milder clinical phenotype, with strain-induced sarco-
meric macro- and microlesions as most prominent find-
ing [11]. This suggests that mutant FLNc interferes with
the maintenance of structural integrity of sarcomeric Z-
discs and mechanical stress resistance. Our present work
shows that the sole and reduced expression of mutant
FLNc significantly aggravates this phenotype. Human
p.W2710X FLNc is prone to aggregate formation in vivo
and in vitro [47, 86], and its heterozygous expression re-
sults in myopathy with lesion and aggregate formation
in muscle fibers around the age of 45 years [36, 86]. The
reason why we did not find protein aggregates even in
aged Hom mice may simply be that mice do not reach a
sufficient age to develop comparable aggregates. We
already previously postulated that lesions most likely define
preclinical disease stages, preceding the formation of protein
aggregates [11]. It was shown that eccentric exercise [21, 53]
and electrical pulse stimulation of cultured myotubes [55]
leads to increased lesion formation. This would imply that
particularly muscles exposed to above average mechanical
stress should be particularly affected. In mice, the soleus
muscle is the most biomechanically strained muscle during
walking, i.e. already under standard housing conditions [30].
Interestingly, FLNc shows its highest expression level in the
soleus muscle (Fig. 1a), and here we observed a higher inci-
dence of lesions in comparison to other muscles (results not
shown). These findings imply that in humans, muscles which
are most strongly strained during walking (like the gastrocne-
mius, semimembranosus and rectus femoris muscles), should
be most strongly affected [30]. Indeed, muscle imaging re-
vealed that the gastrocnemius and semimembranosus mus-
cles are among the most severely affected muscles in human
filaminopathy patients [38]. It is thus very likely that strong
physical exercise would further aggravate this pathology, an
issue important for patient management and to be addressed
in future experiments.
Filamins can act as sensors for mechanical stress [17, 41,
62, 63, 74]. FLNc is a highly dynamic protein capable of re-
locating within seconds, e.g. upon inflicting muscle damage
by laser-induced microdamage or electrical pacing stimula-
tion [43, 51, 55]. In line with this, in a large variety of hu-
man muscle diseases FLNc is dramatically redistributed
away from the Z-disc and recruited to subcellular areas
with functional imbalances and/or particular mechanical
strain such as protein aggregates in myofibrillar myop-
athies, cores in central and minicore myopathies, subsarco-
lemmal space in dystrophinopathies, and target lesions in
neurogenic atrophies [8, 12, 54, 68, 72, 86]. This is substan-
tiated in our Hom mice that show an almost complete
relocalization of (the remaining) mutant FLNc from Z-
discs to myofibrillar lesions and MTJs (see Figs. 3 and 4,
Additional file 1: Figure S4). Notably, this relocalization is
not influenced by the lack of the last 16 amino acids.
Whereas the complete deletion of Ig-like domain 24 abol-
ishes interaction with sarcoglycans [27], truncation of the
C-terminal 16 amino acids alone does not [47]. Likewise,
the interaction with Xin, aciculin/PGM5, myotilin, FATZ,
myopodin and other ligands that bind FLNc in more
amino-terminal regions [20, 45, 51, 81, 82] is not influ-
enced. Accordingly, most of these proteins are found in le-
sions together with FLNc in the WT as well as in the
heterozygous and homozygous mutant situation [19, 34,
43, 51, 55]. Furthermore, in a zebrafish model with knock-
down of endogenous FLNc, heterologous expression of
p.W2710X human FLNc rescues the severe fiber disinte-
gration phenotype, confirming sufficient functionality of
the mutant protein [65]. Since also in these fish mutant
FLNc is sequestered to attachment sites of myofibrils
(comparable to MTJs) and protein aggregates, the authors
concluded that the accompanying lack of FLNc (either
WT or mutant) in Z-discs is a major cause of myofibrillar
instability. The association of FLNc with Xin actin-
binding repeat-containing proteins in MTJs and non-
striated parts of myofibrils, including lesions, reduces
FLNc dynamics and mobility [43] which might protect the
protein in these locations from degradation, and explain
its increased localization in these structures.
It is widely accepted that dimerization of filamins is an es-
sential feature of this protein family [15, 52, 71] and it was
surprising that p.W2711X Hom mice do not have a more se-
vere phenotype. This might imply that dimerization is not an
essential property of FLNc in striated muscles, or that FLNc
does not really cross-link actin filaments in myofibrils. In-
deed, an FLNc variant completely lacking Ig-like domain 24
exhibited Z-disc binding but, when compared to the full
length variant, higher dynamics in fluorescence recovery after
photobleaching (FRAP) experiments [61]. One possible ex-
planation could be an indirect FLNc dimerization achieved
by refilins, that contain multiple filamin binding sites [24], or
other binding partners capable of forming dimers such as
myotilin [66, 85]. An alternative explanation would be the
presence of an additional oligomerization site within FLNc
as reported for FLNb [70], possibly resulting from intermo-
lecular interactions comparable to the intramolecular inter-
actions reported for domain pair 20–21 in FLNa [28, 41].
Indeed, our yeast two hybrid and in vitro interaction studies
were indicative of an additional dimer forming region distinct
from Ig-like domain 24.
This leads to the ultimate question what the function
of FLNc is in sarcomeric lesions. Considering the fact
that FLNc has a plethora of binding partners with highly
different functions, we assume that its major task is to
orchestrate sarcomere repair by acting as an adaptor pro-
tein capable of recruiting both signaling and structural
components. Our immunostainings of macrolesions imply
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that locally titin molecules are maximally stretched to a Z-
disc epitope spacing of approximately 7.2 μm. This dis-
tance is compatible with the length of two titin molecules
stretched to their maximal extension [7, 35]. In these re-
gions FLNc is relocated from Z-discs to the space between
these far distant titin epitopes (see Fig. 4), where a non-
contractile and elastic filamentous scaffold is formed to re-
duce the mechanical stress in order to prevent further
damage and to retain the continuity of the contractile ap-
paratus [43, 55]. As a protein with many binding partners,
FLNc can then recruit other proteins necessary for repair
of the damaged sarcomeres [43].
Further studies addressing the sequential molecular
events and the time course of lesion formation and re-
pair, and the involvement of autophagy in this context
are needed to understand this crucial process in detail.
Conclusions
Homozygosity for the MFM-associated p.W2711X muta-
tion in Flnc in mice leads to increased lesion formation
in skeletal muscle fibers even without additional expos-
ure to strenuous mechanical stress. Our analyses re-
vealed the following major mechanisms contributing to
the pathophysiological condition of filaminopathy:
(1) although Flnc mRNA expression levels are not
reduced, muscle fibers from Hom mice express
highly reduced levels of FLNc protein.
(2) mutant FLNc relocates from Z-discs to particularly
mechanically strained parts of muscle cells;
(3) muscle fibers from Hom mice display dysregulated
sHSP expression: while HSPB7 is lacking, HSPB1,
HSPB5 and HSPB8 are upregulated; the absence of
HSPB7 may directly contribute to sarcomere
disorganization;
(4) dysregulation of CASA is indicated by the absence
of BAG3 from lesions and concomitant
upregulation of the adapter protein SYNPO2;
consequently, clearance of mechanically damaged
proteins from lesions is compromised.
Homozygous FLNC p.W2711X mice will be an excel-
lent tool for investigations aiming at understanding sar-
comeric lesion formation, and to find possibilities to
prevent muscle weakness by lesion formation or to find
methods to enhance lesion repair.
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Figure S1. Histochemistry performed on 8-month-old wild type (WT) and mutant (Hom) 
mouse soleus muscles. No remarkable differences can be noted between WT and mutant mice 
using modified Gömöri trichrome, or the two mitochondrial stains succinate dehydrogenase 
(SDH) and cytochrome oxidase (COX). Scale bar: 200 m. 
 
 Figure S2. Analysis of fiber types in soleus muscle of adult and aged wildtype and Hom 
mice. A. Immunolocalization of myosin heavy chain type I (MHC I) or type IIA (MHC IIA) 
and dystrophin (to identify individual fibers) in transverse cryosections of soleus muscle from 
adult WT or Hom animals (n=3). B,C. The number of fibers expressing a specific myosin 
heavy chain isoform does not differ significantly between adult and aged WT and Hom mice. 
  
 
Figure S3. Distribution of filamin C and vinculin in myotendinous junctions. 
Longitudinal cryosections of soleus muscle from a WT and a Hom mouse stained for FLNc 
and vinculin. Scan settings were identical. Note the accumulation of mutant FLNc within the 
myotendinous junctions identified by vinculin staining, and the reduced level of FLNc in 




 Table S1. Specification of primary antibodies used in this study. Monoclonal antibodies 
marked "DSHB" were obtained from the Developmental Studies Hybridoma Bank, created by 
the NICHD of the NIH and maintained at the University of Iowa, Department of Biology, 
Iowa City, IA 52242. 
Antigen 
(Clone) 
Source/reference Species Immunostaining Immunoblotting 
-actinin  (van der Ven et al., 2000) rabbit polyclonal 1:50 1:500 
BAG3 Proteintech  10599-1-AP rabbit polyclonal - 1:1,000 
Desmin Progen 10570 rabbit polyclonal 1:200 1:500 
Dystrophin 
(Mandra1) DSHB  mouse IgG1 1:10 - 
Filamin A/C 
(RR90) (van der Ven et al., 2000) mouse IgA 1:50 - 
Filamin C 
d16-20 (Kley et al., 2012) rabbit polyclonal 1:50 1:5,000 
Filamin C WT (Chevessier et al., 2015) rabbit polyclonal - 1:100 
GAPDH 
(6C5) Calbiochem CB1001 mouse IgG1 - 1:1,000 
HSPB7 Proteintech  15700-1-AP rabbit polyclonal 1:50 1:500 
Myomesin 
(BB78) (Vinkemeier et al., 1993) mouse IgG2a 1:50 1:500 
MHC I 
(BA-F8) DSHB  mouse IgG2b 1:10 - 
MHC IIA 
(SC71) DSHB  mouse IgG1 1:10 1:50 
MHC IIX 
(6H1) DSHB  mouse IgM 1:10 - 
MHC IIB  




Microsystems Mouse IgG1 1:40 - 
Titin Z-disc 
(T12) (Fürst et al., 1988) mouse IgG1 - 1:200 
-Tubulin 
(YL1/2) 




V9131 mouse IgG1 1:100 - 
Xin (XR1) (van der Ven et al., 2006) mouse IgG1 1:5 1:50 
 
 Table S2. Sequence of oligonucleotides used for quantitative real time PCR 
 
Gene Forward primer Reverse primer 
B2m AATGTGAGGCGGGTGGAACTG CATGGCTCGCTCGGTGACC 
Gapdh AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA 
Flna AAGCCCTCTGCAGTTCTATGTTGAT GCAAACGTTTCAGCAGACAGGGTT 
Flnb CTGAGGAGATTATTCACCCGGA GCGCTGATGGTATCTACCGTG 
Flnc CCTTACTCGCCCTTCCGCATCCAT CTCGGAGCTGTGTAGTAGATGTC 
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